Sector pending / Biological Products, Except Diagnostic SubstancesUpdated 2026-05-10 22:07 UTC

LON/0R0T stock hub

LON/0R0T has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

LON/0R0Tis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

131.4B

London Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

LON/0R0T

In the news

Latest news · LON/0R0T

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E14.6

P25 n/aP50 n/aP75 n/a

Trailing P/E22.2

P25 n/aP50 n/aP75 n/a

ROE101.3

P25 n/aP50 n/aP75 n/a

ROIC19.1

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All LON/0R0T market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

225

Groups with data

Currency

USD

Showing 225 of 225 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United States
Country code	UK
Employees	31,500
Employees Change	3,500%
Employees Change Percent	12.5
Enterprise value	$164.6B
Exchange	London Stock Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Biological Products, Except Diagnostic Substances
Isin	US0311621009
Last refreshed	2026-05-10
Market cap	$131.4B
Price	$331
Price currency	USD
Rev Per Employee	894,821.97x
Sic	2836
Symbol	lon/0R0T
Website	https://www.amgen.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	4.5%
EV Earnings	27.87x
EV/EBIT	18.47x
EV/EBITDA	13.06x
EV/FCF	25.28x
EV/Sales	6.03x
FCF yield	4.96%
Forward P/E	14.61x
P/B ratio	18.88x
P/E ratio	22.24x
P/S ratio	4.66x
PE Ratio10 Y	25.07x
PE Ratio3 Y	28.82x
PE Ratio5 Y	25.59x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	32.63%
EBITDA Margin	45.45%
FCF margin	23.1%
Gross margin	71.44%
Gross Profit	$20.1B
Gross Profit Growth	12.82%
Gross Profit Growth Q	10.41%
Gross Profit Growth3 Y	10.66%
Gross Profit Growth5 Y	6.92%
Net Income	$5.9B
Net Income Growth	31.47%
Net Income Growth Q	5.15%
Net Income Growth3 Y	-0.5%
Net Income Growth5 Y	1.94%
Pretax Margin	24.41%
Profit Margin	20.96%
Profit Per Employee	$187,523
ROA	8.35
Roa5y	8.22
ROCE	17.98
ROE	101.3
Roe5y	101.8
ROIC	19.05
Roic5y	20.52

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	25.24%
Cagr3y	15.73%
Cagr5y	8.9%
Div CAGR3	3.14%
Div CAGR5	7.5%
EPS Growth	31.3
EPS Growth Q	4.38
EPS Growth3 Y	-0.8
EPS Growth5 Y	3.54
FCF Growth	-21.24%
FCF Growth Q	50.71%
FCF Growth3 Y	4.51%
FCF Growth5 Y	-2.65%
OCF Growth	-11.78%
OCF Growth Q	57.37%
OCF Growth10 Y	0.57%
OCF Growth3 Y	7.65%
OCF Growth5 Y	0.55%
Revenue Growth	9.07x
Revenue Growth Q	5.76x
Revenue Growth3 Y	12.43x
Revenue Growth5 Y	8.14x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.41
Assets	$70.1B
Cash	$9.1B
Current Assets	$23.1B
Current Liabilities	$18.3B
Debt	$43.4B
Debt EBITDA	$3.34
Debt Equity	$6.24
Debt FCF	$6.67
Equity	$7B
Interest Coverage	3.92
Liabilities	$63.1B
Long Term Assets	$47B
Long Term Liabilities	$44.8B
Net Cash	$-34.3B
Net Cash By Market Cap	$-26.1
Net Debt EBITDA	$2.68
Net Debt Equity	$4.93
Net Debt FCF	$5.27
Tangible Book Value	$-23.4B
Tangible Book Value Per Share	$-43.31
WACC	6.14

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.26
Inventory Turnover	1.65
Net Working Capital	$-61.3M
Quick ratio	0.85
Working Capital	$4.9B
Working Capital Turnover	$5.4

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.09%
Dividend Growth	0.46%
Dividend Growth Years	7%
Dividend per share	$7.22
Dividend Years	8
Dividend Yield	2.18%
Ex Div Date	2026-02-13
Last Dividend	$1.85
Payout Frequency	Quarterly
Payout Ratio	66.36%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	25.22%
200-day SMA	325.1
3Y total return	55%
50-day SMA	353.2
50-day SMA vs 200-day SMA	50over200
5Y total return	53.18%
All Time High	393
All Time High Change	-15.65%
All Time High Date	2026-03-02
All Time Low	165.9
All Time Low Change	99.8%
All Time Low Date	2018-05-04
ATR	12.1
Beta	0.44
Ch YTD	0.79
High	332.7
High52	393
High52 Date	2026-03-02
High52ch	-15.65%
Low	328.3
Low52	259
Low52 Date	2025-05-12
Low52ch	27.98%
Ma50ch	-6.14%
Price vs 200-day SMA	1.96%
RSI	41.97
RSI Monthly	54.28
RSI Weekly	46.95
Sharpe ratio	0.75x
Sortino ratio	1.45
Total Return	2.09%
Tr YTD	1.49
Tr1m	-2.43%
Tr1w	1.32%
Tr3m	-12.18%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	$9.2B
Operating Income Growth	18.32
Operating Income Growth Q	24.43
Operating Income Growth3 Y	8.22
Operating Income Growth5 Y	5.8
Operating margin	32.63

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	538,248,998%
Net Borrowing	11,736,224
Shares Insiders	0.17%
Shares Institutions	82.91%
Shares Qo Q	0.18%
Shares Yo Y	0.09%
Short Ratio	4.77

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$6.1B
Average Volume	1,599.5x
Bv Per Share	12.9
CAPEX	$-1.6B
Ch1m	-2.43
Ch1w	1.32
Ch1y	21.42
Ch3m	-12.79
Ch3y	41.21
Ch5y	31.02
Ch6m	3.76
Change	1.05%
Change From Open	0.15
Close	328
Days Gap	0.9
Depreciation Amortization	3,500,328,808
Dollar Volume	147,508.6
Earnings Date	2026-04-30
EBIT	$9.2B
EBITDA	$12.8B
EPS	$10.88
F Score	8
FCF	$6.5B
FCF EV Yield	3.96x
Financing CF	-4,025,833,380
Fiscal Year End	December
Founded	1,980
Goodwill	13,697,640,436
Graham Number	76.73524
Graham Upside	-76.85
Income Tax	$974.7M
Investing CF	-1,675,158,660
Is Primary Listing	0
Last Earnings Date	2026-04-30
Last Report Date	2026-03-31
Lynch Fair Value	$74.52
Lynch Upside	-77.52
Ma150	337.5
Ma150ch	-1.78%
Ma20	340.9
Ma20ch	-2.76%
Net CF	2,444,580,540
Next Earnings Date	2026-08-04
Open	331
P FCF Ratio	20.18
P OCF Ratio	16.13
Payment Date	2026-03-06
Position In Range	72.52
Ppne	6,026,551,024
Price Date	2026-05-08
Price EBITDA	$10.25
Relative Volume	0.28x
Revenue	28,186,892,100x
SBC By Revenue	1.3x
Share Based Comp	366,535,620
Tax By Revenue	3.46x
Tax Rate	14.16%
Tr6m	5.22%
Volume	445
Z Score	1.75

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

LON/0R0T dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+2.2%

$7.22 annual per share

Payout ratio

+66.4%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

+7.5%

7 consecutive years of growth

Total shareholder yield

+2.1%

Next ex-dividend date: 2026-02-13

Performance

LON/0R0T stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns LON/0R0T?

Insider, institutional, and short-interest positioning.

Institutional ownership

+82.9%

Share of float held by funds and institutions

Insider ownership

+0.2%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

LON/0R0T momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

42.0

Neutral momentum band

Price vs 200-day MA

+2.0%

50/200-day relationship not available

Beta (5Y)

0.43

Less volatile than the market

Sharpe ratio

0.75

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About LON/0R0T

Hub-level FAQ points readers to the deeper analysis pages.

What is the current lon/0R0T stock rating?

lon/0R0T is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full lon/0R0T analysis?

The full report lives at /stocks/lon/0R0T/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for lon/0R0T?

The latest report frames lon/0R0T around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the lon/0R0T page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.